Close Menu

endometrial cancer

The company — develops tests for the early detection of cancer and other diseases in whole blood — is targeting C$3.7 million in a private placement financing round.

The partners will identify patients with gastrointestinal or endometrial cancers who may benefit from immune checkpoint inhibitor therapy using Biotype's technology.

Researchers separately found that the assay had high concordance with other techniques in cancers including colorectal and endometrial carcinomas.